Literature DB >> 21742025

Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria.

Maria Cristiana Papaleo1, Marco Fondi, Isabel Maida, Elena Perrin, Angelina Lo Giudice, Luigi Michaud, Santina Mangano, Gianluca Bartolucci, Riccardo Romoli, Renato Fani.   

Abstract

The aerobic heterotrophic bacterial communities isolated from three different Antarctic sponge species were analyzed for their ability to produce antimicrobial compounds active toward Cystic Fibrosis opportunistic pathogens belonging to the Burkholderia cepacia complex (Bcc). The phylogenetic analysis performed on the 16S rRNA genes affiliated the 140 bacterial strains analyzed to 15 genera. Just three of them (Psychrobacter, Pseudoalteromonas and Arthrobacter) were shared by the three sponges. The further Random Amplified Polymorphic DNA analysis allowed to demonstrate that microbial communities are highly sponge-specific and a very low degree of genus/species/strain sharing was detected. Data obtained revealed that most of these sponge-associated Antarctic bacteria and belonging to different genera were able to completely inhibit the growth of bacteria belonging to the Bcc. On the other hand, the same Antarctic strains did not have any effect on the growth of other pathogenic bacteria, strongly suggesting that the inhibition is specific for Bcc bacteria. Moreover, the antimicrobial compounds synthesized by the most active Antarctic bacteria are very likely Volatile Organic Compounds (VOCs), a finding that was confirmed by the SPME-GC-MS technique, which revealed the production of a large set of VOCs by a representative set of Antarctic bacteria. The synthesis of these VOCs appeared to be related neither to the presence of pks genes nor the presence of plasmid molecules. The whole body of data obtained in this work indicates that sponge-associated bacteria represent an untapped source for the identification of new antimicrobial compounds and are paving the way for the discovery of new drugs that can be efficiently and successfully used for the treatment of CF infections.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742025     DOI: 10.1016/j.biotechadv.2011.06.011

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  30 in total

1.  Phenotypic and genomic characterization of the Antarctic bacterium Gillisia sp. CAL575, a producer of antimicrobial compounds.

Authors:  Isabel Maida; Marco Fondi; Maria Cristiana Papaleo; Elena Perrin; Valerio Orlandini; Giovanni Emiliani; Donatella de Pascale; Ermenegilda Parrilli; Maria Luisa Tutino; Luigi Michaud; Angelina Lo Giudice; Riccardo Romoli; Gianluca Bartolucci; Renato Fani
Journal:  Extremophiles       Date:  2013-10-23       Impact factor: 2.395

2.  Production and Biotechnological Potential of Extracellular Polymeric Substances from Sponge-Associated Antarctic Bacteria.

Authors:  Consolazione Caruso; Carmen Rizzo; Santina Mangano; Annarita Poli; Paola Di Donato; Ilaria Finore; Barbara Nicolaus; Gaetano Di Marco; Luigi Michaud; Angelina Lo Giudice
Journal:  Appl Environ Microbiol       Date:  2018-01-31       Impact factor: 4.792

3.  Draft genome sequence of the volatile organic compound-producing Antarctic bacterium Arthrobacter sp. strain TB23, able to inhibit cystic fibrosis pathogens belonging to the Burkholderia cepacia complex.

Authors:  Marco Fondi; Valerio Orlandini; Isabel Maida; Elena Perrin; Maria Cristiana Papaleo; Giovanni Emiliani; Donatella de Pascale; Ermenegilda Parrilli; Maria Luisa Tutino; Luigi Michaud; Angelina Lo Giudice; Renato Fani
Journal:  J Bacteriol       Date:  2012-11       Impact factor: 3.490

4.  Identification and analysis of the biological activity of the new strain of Pseudoalteromonas piscicida isolated from the hemal fluid of the bivalve Modiolus kurilensis (F. R. Bernard, 1983).

Authors:  Marina G Eliseikina; Irina A Beleneva; Andrey D Kukhlevsky; Ekaterina V Shamshurina
Journal:  Arch Microbiol       Date:  2021-06-17       Impact factor: 2.552

5.  Characterization of Bacterial, Archaeal and Eukaryote Symbionts from Antarctic Sponges Reveals a High Diversity at a Three-Domain Level and a Particular Signature for This Ecosystem.

Authors:  Susana Rodríguez-Marconi; Rodrigo De la Iglesia; Beatriz Díez; Cássio A Fonseca; Eduardo Hajdu; Nicole Trefault
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 6.  Recent advances and applications of experimental technologies in marine natural product research.

Authors:  Ke Li; Yu-Wen Chung-Davidson; Ugo Bussy; Weiming Li
Journal:  Mar Drugs       Date:  2015-04-29       Impact factor: 5.118

7.  Garlic revisited: antimicrobial activity of allicin-containing garlic extracts against Burkholderia cepacia complex.

Authors:  Daynea Wallock-Richards; Catherine J Doherty; Lynsey Doherty; David J Clarke; Marc Place; John R W Govan; Dominic J Campopiano
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

Review 8.  Chemical diversity of microbial volatiles and their potential for plant growth and productivity.

Authors:  Chidananda Nagamangala Kanchiswamy; Mickael Malnoy; Massimo E Maffei
Journal:  Front Plant Sci       Date:  2015-03-13       Impact factor: 5.753

9.  Bacteria Isolated From the Antarctic Sponge Iophon sp. Reveals Mechanisms of Symbiosis in Sporosarcina, Cellulophaga, and Nesterenkonia.

Authors:  Mario Moreno-Pino; Juan A Ugalde; Jorge H Valdés; Susana Rodríguez-Marconi; Génesis Parada-Pozo; Nicole Trefault
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

10.  Linking Bacterial Endophytic Communities to Essential Oils: Clues from Lavandula angustifolia Mill.

Authors:  Giovanni Emiliani; Alessio Mengoni; Isabel Maida; Elena Perrin; Carolina Chiellini; Marco Fondi; Eugenia Gallo; Luigi Gori; Valentina Maggini; Alfredo Vannacci; Sauro Biffi; Fabio Firenzuoli; Renato Fani
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.